Addressing Antibiotic Stewardship Challenges in Long Term Care Safe Table

This virtual safe table is presented by ECRI and the Institute for Safe Medication Practices PSO in collaboration with Alliance for Quality Improvement and Patient Safety.

The Centers for Disease Control published a 2022 special report titled, “COVID-19 U.S. Impact on Antimicrobial Resistance.” It highlights the impact of pre- and post- pandemic antibiotic prescribing as a public health concern.

During this activity, experts from the Centers for Disease Control and Prevention and Johns Hopkins University Hospital will emphasize antimicrobial stewardship as a foundational and successful tool to reduce the risk of antimicrobial-resistant infections and their spread in long term care facilities.

The discussion includes subject matter experts and peer to peer conversation in a safe and confidential virtual environment. Best practices and barriers are discussed for learning purposes and this information will help leaders enhance care delivery and promote responsible and appropriate antimicrobial usage in long term care.

Learning objectives

During this safe table, our experts will:
1. Focus on how to implement antibiotic stewardship activities in long term care settings
2. Discuss barriers and best practices for antibiotic stewardship in organizations that provide long term care
3. Examine the role of antibiotic stewardship for infection prevention in long term care organizations
4. Interpret the Centers for Disease Control (CDC) Core Elements of Antibiotic Stewardship in Nursing Homes
5. Use antibiotic stewardship processes for quality assurance and performance improvement (QAPI)

Continuing education

• This activity has been approved for up to 1.0 California State Nursing contact hour.

Sarah Kabbani, MD, MSc

Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
Dr. Kabbani completed her internal medicine residency at Wayne State University in Michigan. After working as an academic hospitalist for two years at Beaumont Health System, she joined Emory University in 2011 for her post-doctoral infectious disease fellowship. During her fellowship, she completed a Master of Science in Clinical Research at Emory University, working with population surveillance data and was awarded an NIH T32 training grant in vaccinology.

Morgan Jane Katz, MD MHS

Assistant Professor, Department of Medicine, Johns Hopkins University Hospital
Morgan Katz, MD, MHS, is an assistant professor of medicine at The Johns Hopkins University School of Medicine and the Director of Antimicrobial Stewardship at Johns Hopkins Bayview Hospital. Her area of clinical expertise is infectious diseases. Her research interests lie in infection control and antibiotic stewardship in long-term care facilities. She has focused her career on designing feasible interventions to reduce antimicrobial resistance and transmission of infection in the long-term care setting. She is now serving as a member of the Independent Nursing Home Commission to guide the Centers for Medicare and Medicaid in their response to Coronavirus in long-term care facilities.